With a vision to be reckoned as one of the leaders in the pharmaceutical industry, we are engaged in offering a superior range of Glatiramer Acetate. These drugs consist of the acetate salts of synthetic polypeptides, containing four naturally occurring amino acids: L-glutamic acid, L-alanine, L-tyrosine, and L-lysine. Glatiramer Acetate used to reduce episodes of symptoms in patients with relapsing-remitting multiple sclerosis. We market these medicines at most industry leading prices so that every customer can avail their benefits.
Glatiramer acetate is approved by the FDA for reducing the frequency of relapses, but not for reducing the progression of disability. Observational studies, but not randomized controlled trials, suggest that it may reduce progression of disability.